Literature DB >> 17516294

Insulin resistance and insulin secretion in non-diabetic acromegalic patients.

M Coculescu1, D Niculescu, R Lichiardopol, M Purice.   

Abstract

UNLABELLED: Insulin resistance (IR) can be induced by high amounts of growth hormone (GH). AIM: To set up, in acromegaly without diabetes mellitus, a correlation between the disease activity in GH-secreting adenoma (AA) - assessed by minimum GH serum level during an oral glucose tolerance test (OGTT) - and severity of insulin resistance (IR), assessed by HOMA-IR index.
METHODS: 75 out of 88 consecutive patients with acromegaly hospitalized in our department were included in this study. 13 patients proved to have diabetes mellitus and were excluded. Serum glucose, GH and insulin levels were measured by immunoradiometricassay basal and at 30, 60 and 120 minutes after a 75 g OGTT in 88 patients with active or cured acromegaly. IR was assessed using HOMA-IR index (Homa-IR=basal serum glucose (mg/dl) x basal serum insulin (mU/L)/22.5 x 18). A value over 2.5 was considered indicating IR.
RESULTS: Out of 75 patients without diabetes mellitus, 36 subjects (48%) were presenting with IR (34 with active disease, 2 cured). We found a significant positive correlation (r=0.56, p<0.001) between AA and HOMA-IR. The GH minimal level corresponding to the intersection of the exponential regression curve with the HOMA-IR level of 2.5 was 8.8 ng/mL, a cut-off point indicating IR with 82% specificity and 78% sensitivity. The odds ratio for developing IR becomes significant at a minimum GH level during OGTT of 2 ng/mL (odds ratio 7.6, 95% confidence interval 2-29).
CONCLUSIONS: The severity of IR revealed by acromegaly correlates with GH production. A GH serum level higher than 2 ng/mL during OGTT indicates an increased risk for developing IR. This cut-off level of GH can be used as one of criteria of cured disease, regarding the lack of metabolic effects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17516294     DOI: 10.1055/s-2007-961797

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  8 in total

Review 1.  Acromegaly.

Authors:  Anat Ben-Shlomo; Shlomo Melmed
Journal:  Endocrinol Metab Clin North Am       Date:  2008-03       Impact factor: 4.741

Review 2.  Effect of long-term growth hormone replacement on glucose metabolism in adults with growth hormone deficiency: a systematic review and meta-analysis.

Authors:  He Zhou; Lin Sun; Siwen Zhang; Yingxuan Wang; Guixia Wang
Journal:  Pituitary       Date:  2021-02       Impact factor: 4.107

3.  HOMA-IR in acromegaly: a systematic review and meta-analysis.

Authors:  Betina Biagetti; Anna Aulinas; Anna Casteras; Santiago Pérez-Hoyos; Rafael Simó
Journal:  Pituitary       Date:  2020-10-21       Impact factor: 4.107

4.  Insulin-like growth factor-I correlates more closely than growth hormone with insulin resistance and glucose intolerance in patients with acromegaly.

Authors:  Dan Niculescu; Mariana Purice; Mihail Coculescu
Journal:  Pituitary       Date:  2013-06       Impact factor: 4.107

5.  Improvement of insulin resistance following transsphenoidal surgery in patients with acromegaly: correlation with serum IGF-I levels.

Authors:  K Mori; Y Iwasaki; Y Kawasaki-Ogita; S Honjo; Y Hamamoto; H Tatsuoka; K Fujimoto; H Ikeda; Y Wada; Y Takahashi; J Takahashi; H Koshiyama
Journal:  J Endocrinol Invest       Date:  2013-05-10       Impact factor: 4.256

6.  The ability of β-cells to compensate for insulin resistance is restored with a reduction in excess growth hormone in Korean acromegalic patients.

Authors:  Soo Kyoung Kim; Sunghwan Suh; Ji In Lee; Kyu Yeon Hur; Jae Hoon Chung; Moon-Kyu Lee; Yong-Ki Min; Jae Hyeon Kim; Jong-Hyun Kim; Kwang-Won Kim
Journal:  J Korean Med Sci       Date:  2012-01-27       Impact factor: 2.153

7.  Glucose-dependent Insulinotropic Polypeptide (GIP) Resistance and β-cell Dysfunction Contribute to Hyperglycaemia in Acromegaly.

Authors:  Vikram Singh Shekhawat; Shobhit Bhansali; Pinaki Dutta; Kanchan Kumar Mukherjee; Kim Vaiphei; Rakesh Kochhar; Saroj K Sinha; Naresh Sachdeva; Anura V Kurpad; Kishor Bhat; Sunder Mudaliar; Anil Bhansali
Journal:  Sci Rep       Date:  2019-04-04       Impact factor: 4.379

8.  Metabolic Fingerprint of Acromegaly and its Potential Usefulness in Clinical Practice.

Authors:  Betina Biagetti; J R Herance; Roser Ferrer; Anna Aulinas; Martina Palomino-Schätzlein; Jordi Mesa; J P Castaño; Raul M Luque; Rafael Simó
Journal:  J Clin Med       Date:  2019-09-26       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.